Epigral Limited has informed the Exchange about Conference Call on Monday, 5th May, 2025 to discuss Q4 FY25 Results
EPIGRAL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Epigral Limited has scheduled a conference call for Monday, May 5, 2025, to discuss its financial results for the fourth quarter of FY25. The call is expected to follow the company's official announcement of its Q4 and full-year FY25 results. Investors, analysts, and other stakeholders will be able to participate and hear management's commentary on the quarterly performance. The details of the call, including dial-in numbers and timing, would typically be provided in a separate intimation from the company.
This is a routine corporate communication and does not carry any material information by itself. However, it signals that Q4 FY25 results are imminent, and management's commentary during the call could influence investor sentiment and stock price movement in the days following.